- OKUR Dashboard
- Financials
- Filings
-
Holdings
-
Transcripts
- ETFs
- Insider
- Institutional
- Shorts
-
S-1 Filing
OnKure Therapeutics (OKUR) S-1IPO registration
Filed: 23 Oct 24, 5:03pm
Exhibit 23.1
KPMG LLP Suite 800 1225 17th Street Denver, CO 80202-5598 |
Consent of Independent Registered Public Accounting Firm
We consent to the use of our audit report dated May 13, 2024, with respect to the financial statements of OnKure, Inc., included herein, and to the reference to our firm under the heading “Experts” in the registration statement, and to the reference to our firm under the heading “Experts” in the prospectus.
/s/ KPMG LLP
Denver, Colorado
October 23, 2024
We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.